These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2427395)

  • 1. [Experimental animal research on the thrombolytic effect of acyl-plasmin].
    Nowak G; Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):144-50. PubMed ID: 2427395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrinolytic activity of acyl-urokinase].
    Stürzebecher J; Kroneck I; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):137-43. PubMed ID: 2427394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defibrinogenation by batroxobin and acylated batroxobin in rats.
    Richter M; Paintz M; Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):147-51. PubMed ID: 2459010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation and properties of acylplasmin].
    Aĭsina RB; Kazanskaia NF; Andreenko GV; Liutova LV; Pén'ia K
    Vopr Med Khim; 1985; 31(4):30-4. PubMed ID: 2931900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis.
    Smith RA; Dupe RJ; English PD; Green J
    Thromb Haemost; 1982 Jun; 47(3):269-74. PubMed ID: 6214039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional properties of p-anisoylated plasmin-staphylokinase complex.
    Lijnen HR; Van Hoef B; Smith RA; Collen D
    Thromb Haemost; 1993 Aug; 70(2):326-31. PubMed ID: 8236143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow clearance of acylated, hybrid thrombolytic enzymes.
    Robinson JH; Dodd I; Esmail A; Ferres H; Nunn B
    Thromb Haemost; 1988 Jun; 59(3):421-5. PubMed ID: 3187931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
    Weisdorf DJ; Aldridge JH
    Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of the active center of the enzyme in the triggering mechanism of the compensatory reaction to plasmin].
    Kalishevskaia TM; Golubeva MG; Aĭsina RB; Popova GIu; Bashkov GV
    Biull Eksp Biol Med; 1989 Mar; 107(3):260-4. PubMed ID: 2523741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults.
    Simpson ML; Goldenberg NA; Jacobson LJ; Bombardier CG; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2011 Apr; 127(4):317-23. PubMed ID: 21316746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
    Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatic esters which inhibit plasmin or thrombin by formation of relatively stable acyl enzymes.
    Glover G; Wang CC; Shaw E
    J Med Chem; 1973 Mar; 16(3):262-6. PubMed ID: 4270094
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthetic inhibitors of serine proteinases. 2. Inhibitory effect of amidino benzoic acid homologues and of their esters in comparison with trypsin, plasmin and thrombin].
    Walsmann P; Markwardt F; Richter P; Stürzebecher J; Wagner G; Landmann H
    Pharmazie; 1974 May; 29(5):333-6. PubMed ID: 4277282
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
    Gurewich V; Pannell R; Broeze RJ; Mao J
    J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
    Holvoet P; de Boer A; Verstreken M; Collen D
    Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthetic inhibitors of serine proteinases. 3. Inhibitory effect of basic ally substituted phenyl carbonic acid esters in comparison with trypsin, plasmin and thrombin].
    Stürzebecher J; Markwardt F; Richter P; Wagner G; Walsmann P; Landmann H
    Pharmazie; 1974 May; 29(5):337-8. PubMed ID: 4277283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.